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A dipstick assay for the detection of Brucella-specific immunoglobulin M (IgM) antibodies was evaluated by
studying the serological response of 133 cultures and or serologically confirmed patients with brucellosis in its
different stages along with those of 34 healthy controls. As regards patients with illness less than 3 months in
duration, 93.1% tested positive by the dipstick assay, a percentage similar to that obtained in the standard
serum agglutination test (SAT) (92.0%), somewhat lower than that obtained by culture (100%) and higher than
that obtained by IgM enzyme-linked immunosorbent assay (ELISA) (80.5%). SAT was the most sensitive test
(87.0%) for patients with illness more than 3 months in duration, followed by culture (50%), the dipstick assay
(28.3%), and IgM ELISA (7.5%). The results demonstrate that the dipstick assay could well be used in the
serodiagnosis of patients with acute brucellosis, as well as to identify patients with a long history of the illness.
Under laboratory conditions this test has the advantage of being quick and IgM antibody-specific.
Human brucellosis is still an endemic disease in Asia, Latin
America, and Mediterranean countries. In Spain, it is predom-
inant in rural areas, with a morbidity in 1999 of 3.93 per 105
inhabitants (2).
Owing to the fact that the signs and symptoms of brucellosis
are not pathognomonic, the clinical diagnosis should always be
validated by bacteriological or serological tests. The isolation
of the etiological agent is the only test that provides direct
evidence for the presence of the pathogen. Taking into account
that it is not always possible to achieve this and that the culture
results under optimum conditions cannot be obtained in less
than 4 days, it is often necessary to resort to indirect assays
based on the identification of specific antibodies in the pres-
ence of Brucella antigens (3, 6, 22).
Some of the tests for the diagnosis of human brucellosis (10)
have been described for the diagnosis of acute cases and to
identify patients with a long history of the illness. To diagnose
acute cases, assays have been used to detect the presence of
specific immunoglobulin M (IgM) antibodies, and these in-
clude the radioimmunoassay (15), the enzyme-linked immu-
nosorbent assay (ELISA) (4), the indirect immunofluores-
cence assay (8), and the 2-mercaptoethanol test (17).
Smits et al. (19) have recently developed a simple dipstick
assay for the detection of specific IgM antibodies using a lipo-
polysaccharide (LPS) extract of Brucella as the antigen. This
assay uses strips of nitrocellulose impregnated with LPS of B.
abortus 1119-2 and a stabilized nonenzymatic detection reagent
that consists of a monoclonal anti-human IgM antibody con-
jugated to colloidal dye particles (Palanyl red). The assay is
performed by incubation of the test strip in a mixture of serum
and detection reagent, conjugate binding making IgM antibod-
ies reacting with the LPS epitopes visible.
The objective of this work was to evaluate the clinical utility
of the dipstick assay for the serodiagnosis of patients suspected
of having acute brucellosis. To this end, the dipstick assay was
applied to serum samples of patients suspected to suffer from
brucellosis sent to the authors’ unit, and results were compared
with those obtained for hemoculture, serum agglutination test
(SAT), and a commercially available IgM ELISA.
MATERIALS AND METHODS
Study designs. Single serum samples collected from 167 patients were in-
cluded. The laboratory diagnosis of brucellosis was performed by hemoculture
and SAT, while the Rose Bengal (RB) test was used as a screening test. One
hundred thirty-three patients were diagnosed with brucellosis. The diagnosis of
brucellosis was based on the result of culture as the “gold standard” or on
compatible clinical findings confirmed by a positive result in SAT. Patients were
stratified in two groups: acute (less than 3 months of illness) and cases lasting
more than 3 months from the time of the initial diagnosis of the signs and
symptoms. The majority (65%) of the patients were from rural areas, and the
gender (male/female) ratio was 1.8. The mean age of the patients was 42 years
(range, 16 to 75 years).
Four blood samples from each patients were cultured by Bactec Plus 
aerobic/F and Bactec Plus  anaerobic/F. A 10-ml volume of blood was added
to the flask, and the culture was incubated at 37°C for a maximum of 6 weeks
(Bactec 9240; Becton Dickinson); organisms were identified in accordance with
the taxonomic criteria delineated by Weyantet al. (20).
Serology. The RB was performed as described by Morgan et al. (14) using the
commercial suspension Brucelloslide (BioMe´rieux, Charbonie`res les Banes,
France) as the antigen. SAT was performed according to the method described
by Foz et al. (18), using an antigenic suspension prepared by Laboratorios Atom
Biosystem, Barcelona, Spain. SAT was considered positive when a titer of1:160
was obtained. IgM antibodies specific to B. abortus LPS were measured using
optical density (OD) values generated by an ELISA kit (Laboratorios Vircell,
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Granada, Spain). ELISA results were considered to be equivocal when the OD
was 0.9 and 1.1, and positive when it was 1.1. The dipstick assay for the
detection of Brucella-specific IgM antibodies was conducted by mixing 5 l of the
serum with a detection reagent (final serum dilution of 1:50) in which the
LPS-impregnated nitrocellulose strip was incubated for 3 h at 37°C (7). The
results were classified as negative when no coloring was observed and as positive
when the antigen band showed some degree of staining, its intensity being rated
from 1 to 4 using a colored reference strip (no coloring, 0; pale pink, 1;
pink, 2; intense pink; 3; very intense pink, nearly red, 4).
Statistical analysis. All data were analyzed using the SPSS statistical program
(Statistical Package for the Social Sciences [version 9.0]) and version 6.0 of the
Center for Disease Control and Prevention’s EPI-INFO program (12). The
correlation between the different assays was evaluated using Pearson’s correla-
tion test. The sensitivities of the RB test, SAT, IgM ELISA, and dipstick assay
were calculated using the results obtained for hemoculture-positive confirma-
tion, or a compatible clinical assay with serology 1/160, as the gold standard.
The following staining intensity scale was used: 0, negative; 1, pale pink; 2, pink;
3, intense pink; and 4, very intense pink, nearly red. Statistical significance was
taken as P  0.01.
RESULTS
Hemoculture confirmed the diagnosis of brucellosis in 110
patients, of whom 87 had acute disease and 23 had an evolu-
tion of disease longer than 3 months (Table 1). SAT was
positive in 80 culture-positive patients with acute disease and
in 17 culture-positive and 23 culture-negative patients with
brucellosis with more than 3 months’ evolution. The RB test
was positive for 128 patients, of whom 85 had acute disease and
43 had disease of more than 3 months’ duration. A sensitivity
of 70.7% for the dipstick assay was calculated for the total
group of patients. The sensitivity of the dipstick was 93.1% for
patients with acute disease and 28.3% for those who had been
ill for more than 3 months. The number of SAT or dipstick-
positive patients with acute brucellosis was about the same,
while the number of SAT-positive patients with an evolution of
more than 3 months was much higher. The sensitivity of IgM
ELISA was somewhat lower than that of the dipstick assay.
However, the sensitivities of the two tests were about the same
when equivocal ELISA results were included. SAT was the
only test that gave a positive result for one patient that was
finally diagnosed as having salmonellosis.
The dipstick assay gave a moderate (2) to strong (4)
staining intensity for samples from most dipstick-positive pa-
tients with acute disease. The staining intensity was rated neg-
ative for 6 patients, 1 for 25 patients, 2 for 20 patients, 3
for 17 patients, and 4 for 19 patients (median, 2). The
staining intensity for the patients with illness lasting more than
3 months was rated negative for 33 patients, 1 for 9 patients,
2 for 3 patients, and 4 for 1 patient (median is negative).
Although the number of patients with disease lasting more
than 3 months who were SAT positive was relatively high, the
median SAT titer (1:160) for this group of patients was much
reduced compared with the median SAT titer (1:640) for the
group of patients with acute disease. The median OD value in
ELISA was 1.1 for patients with acute disease and 0.7 for the
other group. The staining intensity of the dipstick assay corre-
lated well with the values for the SAT (r 0.485; P 0.03) and
IgM ELISA (r  0.068; P  0.01) (Table 2). The greater the
staining intensity was, the higher the median values of SAT and
IgM ELISA were.
Discrepant results were obtained for six patients with disease
lasting less than 3 months. One patient was culture positive for
brucellosis but tested negative by all serological tests. Two
patients tested negative by the RB test and SAT, equivocal by
the IgM ELISA, and positive by the dipstick assay, and four
patients tested negative by SAT, equivocal by the IgM ELISA,
and positive by the RB test and dipstick.
DISCUSSION
The main Brucella antigen of diagnostic significance in hu-
man brucellosis is the cell surface smooth LPS (S-LPS). The
bacteria, as any gram-negative in the smooth phase, have a
surface covered by an outer membrane containing an LPS,
which is exposed to the environment. The S-LPS is the anti-
genic component that plays the most important role in agglu-
tination tests like SAT and the RB test (16). Both IgM and IgG
class antibodies are active in these tests. Antibodies to the
S-LPS can also be detected by a variety of tests, including
ELISA, that discriminate between the class of antibody. Ac-
cording to these tests human brucellosis is characterized by an
initial rise of IgM antibodies followed by a switch to IgG class
antibodies (4, 17). Patients suffering relapse show an increase
of IgG but not of IgM (9). These results indicate that at least
two serological methods should be used in the diagnosis of
human brucellosis to distinguish both immunoglobulin classes
and to determine the stage of the infection. Sometimes pa-
tients with brucellosis have SAT titers that are positive but
1/160; therefore, a careful clinical evaluation is called for in
these cases.
The diagnosis of brucellosis is made accurately when Bru-
cella organisms are recovered from the blood, bone marrow, or
other tissues. It is known that patients with acute brucellosis
TABLE 1. Laboratory test performance for Brucella according to
duration of disease
Test
No. (%) of patients with a positive result
3 mo of disease
(n  87)
3 mo of disease
(n  46)
Total
(n  133)
Culture 87 (100) 23 (50) 110 (82)
RB 85 (97.7) 43 (91.5) 128 (96.2)
SAT 80 (92.0) 40 (87.0) 120 (90.2)
Dipstick 81 (93.1) 13 (28.3) 94 (70.7)
IgM ELISAa 70 (80.5) 3 (7.5) 73 (54.9)
IgM ELISAb 83 (95.4) 7 (15.2) 90 (67.7)
a Excluding equivocal results.
b Including equivocal results.
TABLE 2. Correlation of staining intensity of dipstick with result in
SAT and IgM ELISA
Dipstick
score
No. of patients
with disease
duration of:
SATa median
reciprocal titer
(25th–75th
percentile)
IgM ELISAb
median OD
(25th–75th
percentile)3 mo 3 mo
Negative 6 33 160 (160–320) 0.70 (0.60–0.90)
1 25 9 320 (160–320) 1.02 (0.80–1.10)
2 20 3 640 (310–640) 1.10 (1.02–1.12)
3 17 1,280 (640–2,560) 1.12 (1.04–1.35)
4 19 1 5,120 (1,280–5,120) 1.30 (1.10–1.80)
a r  0.485; P  0.03.
b r  0.068; P  0.01.
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have high rates of positive blood culture, ranging from 53.4 to
90% of patients (21).
For this reason we chose hemoculture-positive patients who
did not receive a specific antibiotic treatment for Brucella spp.,
although other patients with brucellosis were not included.
The IgM dipstick assay (19) is one of the tests that have been
adapted to detect IgM antibodies to the S-LPS. The assay
showed a high sensitivity for patients with disease lasting less
than 3 months. The detection of IgM antibodies but not IgG
antibodies explains the low positivity rate of the dipstick assay
and the IgM ELISA for samples collected from patients sick
for more than 3 months. In contrast, the detection rates of the
RB test and SAT, which detect IgM as well as IgG antibodies,
were also high in samples from patients with illness lasting
more than 3 months. The combined results of SAT and the
dipstick assay thus provide an indication of the stage of the
disease for those patients for whom the onset of clinical symp-
toms and signs is not known. Patients with acute illness will test
positive by the dipstick assay, while those who have been ill for
more than 3 months will in all likelihood test negative. How-
ever, the possibility that such patients are suffering a relapse
should not be discounted.
The titers obtained in the SAT show a high degree of cor-
relation with those obtained by testing serum dilutions in the
RB test (3). In this work, three patients with acute disease
confirmed by hemoculture tested negative in the RB test. Two
of these patients tested positive in the dipstick assay (1) and
tested doubtful in the IgM ELISA. The SAT titers of these sera
were 1:40 or less, and these results are in agreement with
previous reports about the sensitivity of the RB test. False-
negative SAT results may occur in patients with a recent in-
fection (i.e., infection onset less than 10 days prior to testing in
all cases) or whose serum contains blocking antibodies. Block-
ing antibodies are IgG or IgA that do not react at pH 7.2 but
do react at pH 5.0. For this reason it is possible to get an
SAT-negative and an RB-positive test. Moreover, in these
cases the ELISA IgG or Coombs IgG are always positive. The
“prozone” phenomenon has little practical importance. The
prozone is seldom observed, and when it occurs the titer ob-
tained is rarely higher than 1/40. (3, 16). In these cases, the
dipstick assay was more sensitive than the RB test and SAT.
The sensitivity of the RB test depends on the antigenic
concentration and the pH (5). Moreover, working with purified
preparations of bovine immunoglobulin (IgG1, IgG2, and
IgM) Díaz and Levieux (9) showed that the response of a given
antibody isotype to the RB test did not depend on the class or
subclass of immunoglobulin but on the commercial antigenic
preparation used. These results offer an explanation for the
differences of opinion found in the literature regarding the
sensitivity of the RB test. For instance, Cernyseva et al. (7)
found that the sensitivity of the test was 68.6%, while Diaz et
al. (11) and Altwegg et al. (1) put the figure at 98.5 and 100%,
respectively. If the RB test is used as a screening test, an effort
must be made to use a preparation that does not give high
sensitivity, thus avoiding false-negative results. The RB test
can give false-negative results that can be due to an unsatis-
factory antigen preparation or to a recent infection.
False-positive reactions can be due to sera from patients
infected with Yersinia enterocolitica 0:9 or from healthy indi-
viduals who have been exposed to smooth Brucella, but these
false-positive results do not pose any problem if other diag-
nostic assays (hemocultures and other serological tests) are
used for confirmation.
Hypothetically speaking, the dipstick assay could replace
tests based on the use of mercaptans (mercaptoethanol or
dithiothreitol), because the latter could be negative in cases in
which exists a great amount of agglutinating IgG antibodies
resistant to the action of these agents as Marrodan et al. (13)
demonstrated. In such cases as these in which SAT values do
not decrease in the presence of 2-mercaptoethanol, the only
way to identify the presence of IgM antibodies is by the dip-
stick assay or ELISA. Although the ELISA technique is con-
sidered one of the most sensitive serological test and is a useful
method for monitoring antibodies in patients undergoing treat-
ment, the lack of a standard antigen, the variations in the
quality of preparations, and the use of various endpoints make
difficult the interpretation of ELISA results. Our objective is to
use the test routinely under laboratory conditions. However,
the positivity rate of 80.5% for patients with illness lasting 3
months or less increase to a rate of 90.5% when patients with
equivocal results are included. These facts could be due to the
rather high background of the technique and/or related with
the difficulties to prepare the antigen and to establish the cutoff
points
The main objective of this work has been to compare, in a
hospital service setting, the dipstick assay, a rapid and simple
technique for detecting IgM antibodies, with other classical
techniques (RB test, SAT, and commercial ELISA), in subjects
with brucellosis. We have shown that the dipstick assay offers
higher sensitivity and easier manipulation than the IgM ELISA
to detect IgM antibodies to Brucella spp. and improves the
interpretation of the results, establishing the cutoff points. The
availability of a rapid and simple test to detect IgM antibodies
to S-LPS may be useful for the diagnosis of human brucellosis.
Our results demonstrate that the dipstick assay could be used
as a rapid and simple alternative to the IgM ELISA for the
serodiagnosis of patients with acute brucellosis.
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